Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,071 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lumenis BE inc | $2,261 | 1 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $134.15 | 8 | $0 (2024) |
| Allergan, Inc. | $100.38 | 5 | $0 (2022) |
| ABBVIE INC. | $99.52 | 5 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $87.50 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $84.88 | 5 | $0 (2023) |
| CooperVision Inc. | $78.57 | 5 | $0 (2024) |
| Shire North American Group Inc | $57.02 | 3 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $56.94 | 3 | $0 (2019) |
| Alcon Vision LLC | $38.39 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $202.85 | 11 | Bausch & Lomb Americas Inc. ($63.88) |
| 2023 | $2,431 | 10 | Lumenis BE inc ($2,261) |
| 2022 | $102.63 | 6 | Novartis Pharmaceuticals Corporation ($52.51) |
| 2021 | $61.09 | 3 | Allergan, Inc. ($31.10) |
| 2020 | $74.91 | 4 | Allergan, Inc. ($43.53) |
| 2019 | $106.12 | 6 | Aerie Pharmaceuticals, Inc. ($56.94) |
| 2018 | $92.49 | 5 | Shire North American Group Inc ($57.02) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Ophthalmology | ||||||
| 09/12/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: EYE CARE | ||||||
| 09/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/21/2024 | CooperVision Inc. | Clariti Contact Lens (Device) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Devices | ||||||
| 06/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: EYE CARE | ||||||
| 05/28/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), VYZULTA | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Ophthalmology | ||||||
| 05/11/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: EYE CARE | ||||||
| 04/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Ophthalmology | ||||||
| 04/15/2024 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Devices | ||||||
| 04/11/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Ophthalmology | ||||||
| 03/12/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Ophthalmology | ||||||
| 10/19/2023 | Alcon Vision LLC | EYSUVIS (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Ophthalmology | ||||||
| 09/19/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Ophthalmology | ||||||
| 08/21/2023 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Ophthalmology | ||||||
| 08/18/2023 | Lumenis BE inc | Optilight (Device) | Food and Beverage | Cash or cash equivalent | $2,261.48 | General |
| Category: Opthamology | ||||||
| 07/18/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: DRY EYE | ||||||
| 06/24/2023 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Devices | ||||||
| 06/07/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P, VUITY | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: EYE CARE | ||||||
| 04/19/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Ophthalmology | ||||||
| 03/06/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Ophthalmology | ||||||
| 02/13/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Ophthalmology | ||||||
| 11/22/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/26/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Ophthalmology | ||||||
| 08/08/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: GLAUCOMA | ||||||
| 08/04/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 430 | 463 | $47,361 | $25,313 |
| 2022 | 8 | 351 | 374 | $57,375 | $20,011 |
| 2021 | 6 | 273 | 288 | $54,740 | $15,805 |
| 2020 | 7 | 362 | 417 | $74,034 | $22,968 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 195 | 195 | $25,984 | $13,427 | 51.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 99 | $9,010 | $6,093 | 67.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 31 | 31 | $5,243 | $2,263 | 43.2% |
| 92250 | Photography of the retina | Office | 2023 | 52 | 54 | $2,904 | $1,191 | 41.0% |
| 92134 | Imaging of retina | Office | 2023 | 36 | 38 | $1,707 | $1,100 | 64.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 20 | 22 | $1,573 | $779.28 | 49.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 24 | 24 | $939.88 | $460.36 | 49.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 158 | 159 | $32,324 | $10,516 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 74 | $8,806 | $4,225 | 48.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 21 | 21 | $4,179 | $2,044 | 48.9% |
| 92250 | Photography of the retina | Office | 2022 | 43 | 45 | $5,077 | $930.27 | 18.3% |
| 92134 | Imaging of retina | Office | 2022 | 25 | 26 | $1,772 | $743.99 | 42.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,520 | $590.34 | 23.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 14 | 14 | $1,179 | $520.12 | 44.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 23 | 23 | $1,518 | $441.45 | 29.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 148 | 148 | $36,260 | $10,209 | 28.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 59 | $8,260 | $3,575 | 43.3% |
| 92250 | Photography of the retina | Office | 2021 | 35 | 35 | $5,600 | $710.59 | 12.7% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 19 | 19 | $1,710 | $565.20 | 33.1% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 12 | 12 | $1,560 | $432.45 | 27.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 15 | 15 | $1,350 | $312.95 | 23.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 138 | 139 | $34,025 | $9,778 | 28.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 82 | 133 | $18,620 | $6,177 | 33.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 52 | 52 | $9,759 | $4,306 | 44.1% |
| 92250 | Photography of the retina | Office | 2020 | 37 | 38 | $6,080 | $1,076 | 17.7% |
About Dr. Stephanie Arnio, OD
Dr. Stephanie Arnio, OD is a Optometrist healthcare provider based in Augusta, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1205363470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephanie Arnio, OD has received a total of $3,071 in payments from pharmaceutical and medical device companies, with $202.85 received in 2024. These payments were reported across 45 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($3,071).
As a Medicare-enrolled provider, Arnio has provided services to 1,416 Medicare beneficiaries, totaling 1,542 services with total Medicare billing of $84,098. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Augusta, ME
- Active Since 05/17/2017
- Last Updated 06/20/2017
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1205363470
Products in Payments
- Optilight (Device) $2,261
- XIIDRA (Drug) $163.63
- LUMIGAN (Drug) $136.03
- Cequa (Drug) $77.30
- Rhopressa (Drug) $56.94
- MIEBO (Drug) $42.15
- BROMSITE (Drug) $38.75
- MyDay Contact Lens (Device) $34.82
- Clariti Contact Lens (Device) $27.60
- DURYSTA (Drug) $23.75
- enVista MX60 IOL (Device) $23.62
- TYRVAYA (Drug) $22.64
- VYZULTA (Drug) $21.65
- Rocklatan (Drug) $20.66
- CEQUA (Drug) $18.10
- EYSUVIS (Drug) $17.73
- XDEMVY (Drug) $16.67
- Multiple Brands Contact Lens (Device) $16.15
- RESTASIS (Drug) $14.37
- XEN (Device) $13.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Augusta
Jessilin Quint, O.d, O.D
Optometrist — Payments: $222,251
Anthony Hartness, O. D, O. D
Optometrist — Payments: $9,392
Dr. Robert Morgan, O.d, O.D
Optometrist — Payments: $5,405
Douglas Ellenberger, Od, OD
Optometrist — Payments: $4,579
Alexandra Grotton
Optometrist — Payments: $3,673
Dr. Keisha Williford, Od, OD
Optometrist — Payments: $3,600